We have qualitatively reviewed this strategy and reaffirmed its Above Average Process and People ratings. Vanguard Value constructs a well-diversified, market-cap-weighted basket of U.S. value stocks at a rock-bottom fee, a recipe for success over the long run. The following text is from April 10, 2023.
Vanguard Value Index Inv VIVAX
- NAV / 1-Day Return 60.42 / +0.15 %
- Total Assets 170.6 Bil
-
Adj. Expense Ratio
0.170%
- Expense Ratio 0.170%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 3,000
- Status Limited
- TTM Yield 2.25%
- Turnover 10%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:21 PM GMT+0
Morningstar’s Analysis VIVAX
Will VIVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Berkshire Hathaway Inc Class B | 3.73 | 6.4 Bil | Financial Services |
Broadcom Inc | 3.02 | 5.2 Bil | Technology |
JPMorgan Chase & Co | 2.81 | 4.8 Bil | Financial Services |
Exxon Mobil Corp | 2.25 | 3.8 Bil | Energy |
UnitedHealth Group Inc | 2.23 | 3.8 Bil | Healthcare |
Procter & Gamble Co | 1.86 | 3.2 Bil | Consumer Defensive |
The Home Depot Inc | 1.86 | 3.2 Bil | Consumer Cyclical |
Johnson & Johnson | 1.86 | 3.2 Bil | Healthcare |
Merck & Co Inc | 1.63 | 2.8 Bil | Healthcare |
AbbVie Inc | 1.57 | 2.7 Bil | Healthcare |